Fulati W, Ma J, Wu M, Qian W, Chen P, Hu Y
Front Immunol. 2024; 15:1382189.
PMID: 38799461
PMC: 11116632.
DOI: 10.3389/fimmu.2024.1382189.
Dabbebi H, Elloumi H, Kechiche C, Hammemi E, Cheikh I, Jmaa A
Tunis Med. 2022; 100(1):37-43.
PMID: 35822330
PMC: 8996311.
Mussolin L, Le Deley M, Carraro E, Damm-Welk C, Attarbaschi A, Williams D
Cancers (Basel). 2020; 12(10).
PMID: 32987765
PMC: 7598675.
DOI: 10.3390/cancers12102747.
Deng Y, Chen X, Huang C, Chen G, Chen F, Lu J
J Cancer. 2019; 10(9):2006-2017.
PMID: 31205561
PMC: 6548167.
DOI: 10.7150/jca.29807.
Ouassou S, Herrak L, Achachi L, Nachite F, Znati K, El Ftouh M
Pan Afr Med J. 2016; 24:181.
PMID: 27795778
PMC: 5072861.
DOI: 10.11604/pamj.2016.24.181.9906.
Acute leukemia in adult Hispanic Americans: a large-population study.
Swords R, Sznol J, Elias R, Watts J, Zelent A, Martin E
Blood Cancer J. 2016; 6(10):e484.
PMID: 27740629
PMC: 5098265.
DOI: 10.1038/bcj.2016.94.
Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress.
Malcolm T, Villarese P, Fairbairn C, Lamant L, Trinquand A, Hook C
Nat Commun. 2016; 7:10087.
PMID: 26753883
PMC: 4729925.
DOI: 10.1038/ncomms10087.
[Clinicopathological features and prognositic analysis of Epstein-Barr virus- positive diffuse large B-cell lymphoma in elderly: 7 cases report and literatures review].
Wang C, Li W, Liu C, Bai O
Zhonghua Xue Ye Xue Za Zhi. 2015; 36(8):698-701.
PMID: 26462644
PMC: 7348266.
DOI: 10.3760/cma.j.issn.0253-2727.2015.08.016.
Targeting autophagy enhances the anti-tumoral action of crizotinib in ALK-positive anaplastic large cell lymphoma.
Mitou G, Frentzel J, Desquesnes A, Le Gonidec S, AlSaati T, Beau I
Oncotarget. 2015; 6(30):30149-64.
PMID: 26338968
PMC: 4745787.
DOI: 10.18632/oncotarget.4999.
Nanopharmacology in translational hematology and oncology.
Tomuleasa C, Braicu C, Irimie A, Craciun L, Berindan-Neagoe I
Int J Nanomedicine. 2014; 9:3465-79.
PMID: 25092977
PMC: 4113407.
DOI: 10.2147/IJN.S60488.
Interleukin-2 Functions in Anaplastic Large Cell Lymphoma Cells through Augmentation of Extracellular Signal-Regulated Kinases 1/2 Activation.
Ito M, Zhao N, Zeng Z, Zhou X, Chang C, Zu Y
Int J Biomed Sci. 2013; 7(3):181-90.
PMID: 23675235
PMC: 3614832.
High numbers of tumor-associated macrophages correlate with poor prognosis in patients with mature T- and natural killer cell lymphomas.
Lin Z, Bai B, Cai Q, Cai Q, Wang X, Wu X
Med Oncol. 2012; 29(5):3522-8.
PMID: 22562823
DOI: 10.1007/s12032-012-0244-6.
Serum neuron-specific enolase is correlated with clinical outcome of patients with non-germinal center B cell-like subtype of diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy.
Wang L, Liu P, Chen X, Geng Q, Lu Y
Med Oncol. 2011; 29(3):2153-8.
PMID: 21877195
DOI: 10.1007/s12032-011-0049-z.
Expression of JL1 in Burkitt lymphoma is associated with improved overall survival.
Hwang I, Go H, Jeon Y, Ko Y, Yoon D, Suh C
Virchows Arch. 2011; 459(4):353-9.
PMID: 21814778
DOI: 10.1007/s00428-011-1134-6.
A nanocomplex that is both tumor cell-selective and cancer gene-specific for anaplastic large cell lymphoma.
Zhao N, Bagaria H, Wong M, Zu Y
J Nanobiotechnology. 2011; 9:2.
PMID: 21281497
PMC: 3045295.
DOI: 10.1186/1477-3155-9-2.
The tyrosine 343 residue of nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) is important for its interaction with SHP1, a cytoplasmic tyrosine phosphatase with tumor suppressor functions.
Hegazy S, Wang P, Anand M, Ingham R, Gelebart P, Lai R
J Biol Chem. 2010; 285(26):19813-20.
PMID: 20424160
PMC: 2888392.
DOI: 10.1074/jbc.M110.121988.
